Skip to main content
Premium Trial:

Request an Annual Quote

Caprotec Enters Second Collaboration with Bayer CropScience for Use of CCMS Technology

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research collaboration with Bayer CropScience to identify and study an agrochemical target.

The collaboration will use Caprotec's Capture Compound Mass Spectrometry technology to profile the interactions of Bayer CropScience compounds with the proteome of various biological systems. The agreement builds on a previous collaboration between the two companies begun in December 2011 that similarly used the CCMS technology for analysis of a target of interest.

Caprotec's CCMS technology uses capture compounds to reversibly bind target proteins on the basis of small molecule-protein interactions. The captured proteins are then pulled out and analyzed via mass spectrometry.

Financial and other terms of the agreement were not disclosed.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.